Cancer Center Announces First Patient Has Received City of Hope’s Novel, Potentially Cancer-Stopping Pill

The Phase 1 clinical trial tests the safety of providing City of Hope-developed AOH1996 to people with reoccurring solid tumors. LOS ANGELES, Oct. 19, 2022 /PRNewswire/ -- City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced...

Click to view original post